(Q34444187)

2 August 2017

title

Glycosaminoglycan sulodexide decreases albuminuria in diabetic patients (English)

1 reference

2 August 2017

Skrha J

1

1 reference

2 August 2017

Perusicová J

series ordinal

2

1 reference

2 August 2017

Pont'uch P

series ordinal

3

1 reference

2 August 2017

Oksa A

series ordinal

4

1 reference

2 August 2017

publication date

1 October 1997

1 reference

Diabetes Research and Clinical Practice

2 August 2017

published in

1 reference

2 August 2017

volume

38

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

25-31

1 reference

Prognosis for Juvenile Diabetics with Nephropathy and Failing Renal Function

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900076-4

7 January 2021

Prognosis of diabetics with diabetes onset before the age of thirty-one. I. Survival, causes of death, and complications

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900076-4

7 January 2021

Evidence of changes in renal charge selectivity in patients with type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900076-4

7 January 2021

Protective effect of heparin on renal glomerular anionic sites of streptozotocin-injected rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900076-4

7 January 2021

Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900076-4

7 January 2021

Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900076-4

7 January 2021

Effect of sulphated glycosaminoglycans on albuminuria in patients with overt diabetic (type 1) nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900076-4

7 January 2021

Glycosaminoglycans: a new paradigm in the prevention of proteinuria and progression of glomerular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900076-4

7 January 2021

The observation of heparin on endothelium after injection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900076-4

7 January 2021

Effects of heparin and aminoguanidine on glomerular basement membrane thickening in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900076-4

7 January 2021

Role of glycosaminoglycans (GAGs) in regulation of the immunogenicity of human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900076-4

7 January 2021

Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900076-4

7 January 2021

Heparan sulfate proteoglycan in the glomerular basement membrane in type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900076-4

7 January 2021

Urinary heparan sulphate proteoglycan excretion is abnormal in insulin dependent diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900076-4

7 January 2021

Albuminuria reflects widespread vascular damage. The Steno hypothesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900076-4

7 January 2021

A Six-year Follow-up of the Relationship Between N-Acetyl-β-glucosaminidase and Albuminuria in Relation to Retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900076-4

7 January 2021

Heparin stimulates proteoglycan synthesis by vascular smooth muscle cells while supressing cellular proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900076-4

7 January 2021

Heparin stimulates the synthesis and modifies the sulfation pattern of heparan sulfate proteoglycan from endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900076-4

7 January 2021

Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2897%2900076-4

7 January 2021

10.1016/S0168-8227(97)00076-4

Identifiers

DOI

1 reference

2 August 2017

1 reference